• Return to Headlines

Coherus Bioscien Shares Up 46.5% Since SmarTrend's Buy Recommendation (CHRS)

By Shiri Gupta

SmarTrend identified an Uptrend for Coherus Bioscien (NASDAQ:CHRS) on March 12th, 2018 at $11.96. In approximately 6 months, Coherus Bioscien has returned 46.53% as of today's recent price of $17.53.

In the past 52 weeks, Coherus Bioscien share prices have been bracketed by a low of $8.05 and a high of $20.66 and are now at $17.52, 118% above that low price. The 200-day and 50-day moving averages have moved 1.30% higher and 1.37% higher over the past week, respectively.

Coherus Biosciences, Inc. is a biopharmaceutical company. The Company develops biosimilar therapeutics to aid patients.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Coherus Bioscien shares.

Log in and add Coherus Bioscien (CHRS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights coherus bioscien

Ticker(s): CHRS